BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 30063615)

  • 1. Deactivation of Implantable Cardioverter-Defibrillators in Heart Failure: A Systematic Review.
    Herman M; Horner K; Ly J; Vayl Y
    J Hosp Palliat Nurs; 2018 Feb; 20(1):63-71. PubMed ID: 30063615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Original research: deactivation of ICDs at the end of life: a systematic review of clinical practices and provider and patient attitudes.
    Russo JE
    Am J Nurs; 2011 Oct; 111(10):26-35. PubMed ID: 21926561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients' perception of implantable cardioverter defibrillator deactivation at the end of life.
    Hill L; McIlfatrick S; Taylor B; Dixon L; Harbinson M; Fitzsimons D
    Palliat Med; 2015 Apr; 29(4):310-23. PubMed ID: 25239128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable cardioverter defibrillator knowledge and end-of-life device deactivation: A cross-sectional survey.
    McEvedy SM; Cameron J; Lugg E; Miller J; Haedtke C; Hammash M; Biddle MJ; Lee KS; Mariani JA; Ski CF; Thompson DR; Chung ML; Moser DK
    Palliat Med; 2018 Jan; 32(1):156-163. PubMed ID: 28678000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable cardioverter defibrillator deactivation and advance care planning: a focus group study.
    Stoevelaar R; Brinkman-Stoppelenburg A; van Driel AG; van Bruchem-Visser RL; Theuns DA; Bhagwandien RE; Van der Heide A; Rietjens JA
    Heart; 2020 Feb; 106(3):190-195. PubMed ID: 31537636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient perceptions of implantable cardioverter-defibrillator deactivation discussions: A qualitative study.
    MacIver J; Tibbles A; Billia F; Ross H
    SAGE Open Med; 2016; 4():2050312116642693. PubMed ID: 27110361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Planning for Deactivation of Implantable Cardioverter Defibrillators at the End of Life in Patients With Heart Failure.
    Brady DR
    Crit Care Nurse; 2016 Dec; 36(6):24-31. PubMed ID: 27908943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of patients with ICDs at the end of life (EOL): a qualitative study.
    Kelley AS; Mehta SS; Reid MC
    Am J Hosp Palliat Care; 2008 Dec-2009 Jan; 25(6):440-6. PubMed ID: 18812618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deactivation of implantable cardioverter-defibrillators: results of patient surveys.
    Herman D; Stros P; Curila K; Kebza V; Osmancik P
    Europace; 2013 Jul; 15(7):963-9. PubMed ID: 23447573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spouses' reflections on implantable cardioverter defibrillator treatment with focus on the future and the end-of-life: a qualitative content analysis.
    Fluur C; Bolse K; Strömberg A; Thylén I
    J Adv Nurs; 2014 Aug; 70(8):1758-69. PubMed ID: 24321029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
    Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter defibrillator devices: when, how and who should discuss deactivation with patients: a systematic literature review.
    Freemantle M; Murtagh F
    BMJ Support Palliat Care; 2022 Dec; 12(4):359-367. PubMed ID: 33963003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. End-of-life care in patients with implantable cardioverter defibrillators: a MADIT-II substudy.
    Sherazi S; McNitt S; Aktas MK; Polonsky B; Shah AH; Moss AJ; Daubert JP; Zareba W
    Pacing Clin Electrophysiol; 2013 Oct; 36(10):1273-9. PubMed ID: 23731284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moral Distress at the End of a Life: When Family and Clinicians Do Not Agree on Implantable Cardioverter-Defibrillator Deactivation.
    Steiner JM; Patton KK; Prutkin JM; Kirkpatrick JN
    J Pain Symptom Manage; 2018 Feb; 55(2):530-534. PubMed ID: 29191724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Octo- and nonagenarians' outlook on life and death when living with an implantable cardioverter defibrillator: a cross-sectional study.
    Thylén I; Moser DK; Strömberg A
    BMC Geriatr; 2018 Oct; 18(1):250. PubMed ID: 30342484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence and impact of implantable cardioverter defibrillator shocks in the last phase of life: An integrated review.
    Stoevelaar R; Brinkman-Stoppelenburg A; Bhagwandien RE; van Bruchem-Visser RL; Theuns DA; van der Heide A; Rietjens JA
    Eur J Cardiovasc Nurs; 2018 Aug; 17(6):477-485. PubMed ID: 29772911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Implantable cardioverter-defibrillator deactivation at the end of life: ethical, clinical and communication issues].
    Romanò M; Piga MA; Bertona R; Negro R; Ruggeri C; Zorzoli F; Villani R
    G Ital Cardiol (Rome); 2017 Feb; 18(2):139-149. PubMed ID: 28398367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do implantable cardioverter defibrillators complicate end-of-life care for those with heart failure?
    Waterhouse E; Ahmad F
    Curr Opin Support Palliat Care; 2011 Dec; 5(4):307-11. PubMed ID: 22025091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decision-Making of Patients With Implantable Cardioverter-Defibrillators at End of Life: Family Members' Experiences.
    Lee MC; Sulmasy DP; Gallo J; Kub J; Hughes MT; Russell S; Kellogg A; Owens SG; Terry P; Nolan MT
    Am J Hosp Palliat Care; 2017 Jul; 34(6):518-523. PubMed ID: 27034436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.